The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
The Body Covers:
The 1st International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
Rancho Bernardo Inn, San Diego, CA

June 26-29, 1999

The recent expansion in the number and variety of therapeutic tools available to treat HIV has led to significant advances in treatment options. While advantageous to the patient, the profusion of treatment options requires the treating clinician to keep abreast of the adverse effects possible from the use of such an array of drug combinations. The current knowledge base is critical to managing the adverse effects of antiviral therapies and to achieving long-term treatment success.

While many adverse side effects have already been identified for a number of existing antiviral drugs, the effects of newer drugs and the events caused by novel drug combinations are still a matter of investigation. In addition, interactions between this larger array of drugs and the virus itself are not yet fully understood. It is thus imperative that leading investigators begin to marshal clinical knowledge and the latest research findings to further the understanding of adverse drug interactions induced by current and future treatment options.

In establishing the first workshop on this rapidly evolving topic the organizers hope to provide a forum for active discussion and leading edge information. Much of this first meeting will cover lipodystrophy, a topic currently under much discussion and investigation. The aims of this workshop are to provide a medium for participants to discover the results of the latest scientific developments and to establish a consensus definition for lipodystophy. The purpose of this workshop is to stimulate the effort to further extend and enhance knowledge of those involved in developing and managing the treatment of HIV and AIDS.

Following are selected conference summaries of abstracts reported exclusively for The Body by Abhimanyu Garg, M.D., Associate Program Director, General Clinical Research Center, The Center for Human Nutrition and Associate Professor of Internal Medicine, the University of Texas Southwestern Medical Center at Dallas, and Joep Lange, M.D., Professor of Internal Medicine, Academic Medical Centre, University of Amsterdam, and Director, National AIDS Therapy Evaluation Centre, Netherlands.

Funding for this conference coverage at The Body is provided, in part, by an unrestricted educational grant by Agouron Pharmaceuticals, Inc. and Bristol-Myers Squibb Immunology.

Conference Summaries:

Sunday, June 27, 1999

Monday, June 28, 1999

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.